Other official information and services: www.belgium.be
Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2020C521 Product name: daratumumab, bortezomib, thalidomide en dexamethason
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
- Application number:
- 2020C/521
- Type:
- Certificate
- SPC type:
- Medical
- Basic patent number:
- 078178167
- Status:
- Open & Published
- Publication number:
- 2020C521
- 1rst applicant's nationality:
- Procedural language:
- Dutch
Marketing authorization
- Marketing authorization number:
- EU/1/16/1101, als gewijzigd bij besluit C(2020)398
- Marketing authorization type:
- National/EU
- Designates country:
- No
- Marketing authorization date:
- 24/05/2016
- Marketing authorization status:
- Accepted
- Marketing authorization country:
- Belgium (BE)
Dates
- Filing date:
- 01/07/2020
- First marketing authorization date:
- 24/05/2016
- Grant date:
- Activation date:
- BE Publication date:
- 02/07/2020
- Lapsed date:
- Expiration date (if granted and all annual fees paid):
- Basic SPC Expiration (if granted and all annual fees paid):
- 24/05/2031
- SPC/SPC Extension Expiration (if granted and all annual fees paid):
- Rejection date:
- Withdrawal date:
Applicant
1
- Name:
- Genmab A/S
- Legal Form:
- From:
- 04/07/2025
- Address:
- Carl Jacobsens Vej 30, 2500 Valby, Denmark (DK)
- To:
2
- Name:
- Genmab A/S
- Legal Form:
- A/S
- From:
- 02/07/2020
- Address:
- Kalvebod Brygge 43, 1560, Copenhagen, Denmark (DK)
- To:
- 04/07/2025
Agent
1
- Name:
- NLO
- Legal Form:
- From:
- 27/11/2024
- Address:
- New Babylon City Offices Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)
- To:
2
- Name:
- NLO
- Legal Form:
- From:
- 02/07/2020
- Address:
- Technologiepark 122, 9052, ZWIJNAARDE - GENT, Belgium (BE)
- To:
- 27/11/2024
Publication
Bulletin
1
- Bulletin heading:
- CO
- Journal edition number:
- 2025/14
- Publication date:
- 04/09/2025
- Description:
- Contains data concerning registered assignments or changes of the names of applicants and holders
2
- Bulletin heading:
- SPC
- Journal edition number:
- 2020/18
- Publication date:
- 21/08/2020
- Description:
- Contains data concerning applications for- or granted Supplementary Protection Certificates
Deed
Change of owner(s)
- Change Kind / Decision Type:
- Other
- Deed number:
- RC2025100474A
- Registration date:
- 04/07/2025
- License effective date:
- License expiration date:
- Scope of license:
- Deed filer:
- NLO
- Bulletin edition number:
- Text:
- changement d'adresse
- Country code:
- Updated license number:
- Terminated license number:
Removed pledgee
- Name:
- Address:
Changed pledgee
- Name:
- Address:
Removed usufructuary
- Name:
- Address:
Added usufructuary
- Name:
- Address:
Changed usufructuary
- Name:
- Address:
| Filing date | Document type | Publication Type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|---|
| 08/07/2021 | MA Official Publication | Official Publication of 1st Marketing Authorization | 2 | /3/3/5/4/1/0722014533/docs/2020c521_0_maofficialpublication_20210709_084739133.pdf | |||
| 07/05/2021 | Incoming Correspondence (Post) | 32 | /3/3/5/4/1/0722014533/docs/2020c521_1_incomingcorrespondencepaper_20210507_032820610.pdf | ||||
| 08/07/2021 | Abstract Product Characteristics | Abstract of the characteristics of the product | 14 | /3/3/5/4/1/0722014533/docs/2020c521_2_abstractproductcharacteristics_20210709_084738490.pdf | |||
| 01/07/2020 | MA Official Publication | Official Publication of 1st Marketing Authorization | 11 | /3/3/5/4/1/0722014533/docs/2020c521_3_maofficialpublication_20200702_084650087.pdf | |||
| 01/07/2020 | General Document | Other | 4 | /3/3/5/4/1/0722014533/docs/2020c521_4_generaldocument_20200702_084649406.pdf | |||
| 02/07/2020 | Publication | I1 | 1 | /3/3/5/4/1/0722014533/docs/2020c521_5_i1document_20200702_101728079.pdf | |||
| 08/07/2021 | Incoming Correspondence (Email) | Regularisation of SPC | 1 | /3/3/5/4/1/0722014533/docs/2020c521_6_incomingcorrespondenceelectronic_20210709_084738009.pdf | |||
| 01/12/2021 | Outgoing Correspondence | 2 | /3/3/5/4/1/0722014533/docs/2020c521_7_outgoingcorrespondence_20211206_021746590.pdf | ||||
| 08/07/2021 | Marketing Authorization | 1st Marketing Authorization (EU) | 4 | /3/3/5/4/1/0722014533/docs/2020c521_8_marketingauthorization_20210709_084739612.pdf | |||
| 01/04/2022 | Incoming Correspondence (Email) | Regularisation of SPC | 4 | /3/3/5/4/1/0722014533/docs/2020c521_9_incomingcorrespondenceelectronic_20220402_084547311.pdf | |||
| 02/07/2020 | Outgoing Correspondence | 2 | /3/3/5/4/1/0722014533/docs/2020c521_10_outgoingcorrespondence_20200703_022917662.pdf | ||||
| 01/07/2020 | Application Form | 4 | /3/3/5/4/1/0722014533/docs/2020c521_11_applicationform_20200702_084700658.pdf | ||||
| 02/02/2022 | Outgoing Correspondence | 1 | /3/3/5/4/1/0722014533/docs/2020c521_12_outgoingcorrespondence_20220202_033032228.pdf | ||||
| 10/05/2021 | Abstract Product Characteristics | Abstract of the characteristics of the product | 30 | /3/3/5/4/1/0722014533/docs/2020c521_13_abstractproductcharacteristics_20210512_111557176.pdf | |||
| 01/07/2020 | Abstract Product Characteristics | Abstract of the characteristics of the product | 27 | /3/3/5/4/1/0722014533/docs/2020c521_14_abstractproductcharacteristics_20200702_084651689.pdf | |||
| 01/07/2020 | Marketing Authorization | 1st Marketing Authorization (EU) | 3 | /3/3/5/4/1/0722014533/docs/2020c521_15_marketingauthorization_20200702_084651196.pdf | |||
| 26/01/2022 | Incoming Correspondence (Email) | Cover letter | 3 | /3/3/5/4/1/0722014533/docs/2020c521_16_incomingcorrespondenceelectronic_20220127_084541335.pdf | |||
| 27/11/2024 | Request For Change | Letter and/or Form requesting a change in the Register | 2 | /3/3/5/4/1/0722014533/docs/2020c521_17_rfc_20241127_012947133.pdf | |||
| 27/11/2024 | Outgoing Correspondence | Outgoing Correspondence | 2 | /3/3/5/4/1/0722014533/docs/2020c521_18_206455_pie.rfc.per.notif.pdf | |||
| 04/07/2025 | Request For Change | Letter and/or Form requesting a change in the Register | 3 | /3/3/5/4/1/0722014533/docs/2020c521_19_rfc_20250705_084531069.pdf | |||
| 24/07/2025 | Outgoing Correspondence | Outgoing Correspondence | 2 | /3/3/5/4/1/0722014533/docs/2020c521_20_219069_pie.rfc.per.notif.pdf | |||
| 04/07/2025 | Incoming Correspondence (Email) | Cover letter | 1 | /3/3/5/4/1/0722014533/docs/2020c521_21_incomingcorrespondenceelectronic_20250705_084531265.pdf | |||
| 04/07/2025 | Outgoing Correspondence | 1 | /3/3/5/4/1/0722014533/docs/2020c521_22_outgoingcorrespondence_20250705_084530926.pdf |